BNR News and Press, Burning Rock Biotech Limited From 06/08/23

2023-06-08 09:56:00 ET Summary Burning Rock’s net loss narrowed 29% to 185 million yuan in the first quarter from the same period a year earlier, helped by lower R&D and sales expenses. Revenues from R&D services for drug companies more than doubled, becoming the co...

GUANGZHOU, China, June 08, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”) is pleased to announce that our flagship comprehensive genomic profiling (CGP) product, OncoScreen TM Plus, was featured in ...

2023-05-30 10:25:19 ET Burning Rock Biotech Limited (BNR) Q1 2023 Earnings Conference Call May 30, 2023 08:00 AM ET Company Participants Yusheng Han - Founder, Chairman & CEO Leo Li - CFO Joe Zhang - CTO Conference Call Participants Alexis Yan - M...

2023-05-30 01:13:59 ET Burning Rock Biotech press release ( NASDAQ: BNR ): Q1 GAAP EPS of -$0.26. Revenue of $20.8M (-2.8% Y/Y). Non-GAAP gross margin was 75.7% for the three months ended March 31, 2023, compared to 68.4% for the same period in 2022. Cash, cash e...

GUANGZHOU, China, May 30, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today re...

GUANGZHOU, China, April 20, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing technology in the field of precision oncology, announces th...

2023-03-28 11:46:53 ET The following slide deck was published by Burning Rock Biotech Limited in conjunction with their 2022 Q4 earnings call. For further details see: Burning Rock Biotech Limited 2022 Q4 - Results - Earnings Call Presentation

2023-03-28 11:44:05 ET Burning Rock Biotech Limited (BNR) Q4 2022 Earnings Conference Call March 28, 2023, 08:00 AM ET Company Participants Yusheng Han - Founder, Chairman and Chief Executive Officer Joe Zhang - CTO Leo Li - CFO Conference Call Participants...

2023-03-28 03:35:11 ET Burning Rock Biotech press release ( NASDAQ: BNR ): Q4 GAAP EPS of -$0.31. Revenue of $20.6M (-10.9% Y/Y). Non-GAAP gross margin was 77.6% for the three months ended December 31, 2022, compared to 72.9% for the same period in 2021. Outlook:...

GUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today ...